Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Metasphere Labs Inc. R (H1N.F)

0.0490
-0.0011
(-2.20%)
At close: April 25 at 3:29:02 PM GMT+2
Loading Chart for H1N.F
  • Previous Close 0.0501
  • Open 0.0569
  • Bid 0.0501 x --
  • Ask 0.0540 x --
  • Day's Range 0.0490 - 0.0569
  • 52 Week Range 0.0400 - 3.2800
  • Volume 10,000
  • Avg. Volume 2,753
  • Market Cap (intraday) 2.156M
  • Beta (5Y Monthly) 4.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Metasphere Labs Inc. focus on leveraging blockchain, metaverse, and AI technologies. The company provides ClimateBot, a digital platform equipped with calculators designed to assess environmental impacts on calculating carbon footprints; and CarbonBot. The company was formerly known as Looking Glass Labs Ltd. and changed its name to Metasphere Labs Inc. in February 2024. Metasphere Labs Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

www.metasphere.earth

--

Full Time Employees

July 31

Fiscal Year Ends

Recent News: H1N.F

View More

Performance Overview: H1N.F

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

H1N.F
18.60%
S&P/TSX Composite index (^GSPTSE)
0.37%

1-Year Return

H1N.F
92.60%
S&P/TSX Composite index (^GSPTSE)
12.91%

3-Year Return

H1N.F
99.84%
S&P/TSX Composite index (^GSPTSE)
17.60%

5-Year Return

H1N.F
99.87%
S&P/TSX Composite index (^GSPTSE)
71.36%

Compare To: H1N.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: H1N.F

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    2.16M

  • Enterprise Value

    1.64M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.78

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.81

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -133.95%

  • Return on Assets (ttm)

    -44.04%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    916.13k

  • Net Income Avi to Common (ttm)

    -1.23M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    287.28k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.54M

Research Analysis: H1N.F

View More

Company Insights: H1N.F

Research Reports: H1N.F

View More